BCYC Q1 2023 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+26.8% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$42M-853.8% margin

Net Income

-$39M-797.9% margin

EPS (Diluted)

$-1.30

QoQ Revenue Growth

+53.7%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$49M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$429M

Total Liabilities

$186M

Stockholders' Equity

$243M

Cash & Equivalents

$294M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+26.8%
Gross Profit	$5M	$4M	+26.8%
Operating Income	-$42M	-$27M	-52.7%
Net Income	-$39M	-$28M	-41.7%